Biogen Stock Gains On Promising Final Data From Alzheimer's Drug Trial

Sun Herald Business

Nov 30, 2022

"These peer-reviewed, published results show lecanemab will provide patients more time to participate in daily life and live independently," the Alzheimer's Association said. Bioge…